Companies: 10,795·Total market cap: $144.5T
Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc.

ARMPAMEXHealthcare● Active
$7.50
+$0.00(+0.00%)
Market Cap$275331000
P/E Ratio
52W High$16.34
52W Low$1.74
Overview

Armata Pharmaceuticals, Inc. (ARMP) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ARMP · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-7.77armp eps ttm · armp earnings per shareEarnings history
PE Ratio (TTM)armp pe ratio ttm · armp price to earningsPE Ratio deep dive
Revenue (TTM)$3.0Marmp revenue ttm · armp annual revenueFull revenue history
Dividend YieldNo Dividenddoes armp pay dividends · armp dividend yieldDividend history
Shares Outstanding36.2Marmp shares outstanding · armp floatShares outstanding history
Next EarningsAug 11, 2026Est.armp earnings date · armp next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$4.9M▼ 5.22% YoY
202320242025
armata pharmaceuticals, inc. revenue · armp revenue 2025
FY 2025Net Income-$173.8M▼ 818.79% YoY
202320242025
armata pharmaceuticals, inc. net income · armp profit 2025
FY 2025EPS$-4.80▼ 823.08% YoY
202320242025
armp eps · armata pharmaceuticals, inc. earnings per share 2025
TTM:Revenue: $3.0MNet Income: -$282.6MEPS: $-7.77View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy4 analystsis armp a buy · armp analyst rating
Strong Buy
0
Buy
4
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$15.00Low
$7.50Current
$15.00Avg Target100.00% upside
$15.00High
armp price target · armp 12 month forecast

Total: 4 · Buy rate: 100.0%

The ARMP analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $15.00, representing +100.00% upside from the current price of $7.50.

Stock Performance

Full History
1D+3.07%
1W-2.15%
1M-6.87%
3M-27.08%
YTD+23.09%
1Y+294.39%
5Y+91.34%

About Armata Pharmaceuticals, Inc.

CEODeborah L. Birx
IPO DateMay 20, 1994
Employees60
CountryUS

Armata Pharmaceuticals, Inc. a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its p…

what is armata pharmaceuticals, inc. · armp stock overview · armata pharmaceuticals, inc. company profile · who is armata pharmaceuticals, inc. ceo · armp AMEX · armata pharmaceuticals, inc. headquarters · armata pharmaceuticals, inc. business segments

About Stock Overview & Key Data

Armata Pharmaceuticals, Inc. (ARMP) is a Healthcare company in the Biotechnology industry, listed on AMEX since May 20, 1994. As of the latest trading session, ARMP stock price is $7.50, with a market capitalization of $283.8M. The stock has returned +294.39% over the past 12 months and +23.09% year-to-date.

According to 4 Wall Street analysts, the consensus rating for Armata Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $15.00. In fiscal year 2025, Armata Pharmaceuticals, Inc. reported revenue of $4.9M and net income of -$173.8M. For detailed data — including Armata Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Armata Pharmaceuticals, Inc. (ARMP) stock price is $7.50. The stock is traded on AMEX under the ticker symbol ARMP. The 52-week range is $1.74 – $16.34.

ARMP stock priceARMP quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice